鎌状赤血球症は、兄弟姉妹比較研究において喘鳴の固有のリスクである
Suhei C Zuleta De Bernardis1,2, Okeleji Olayinka1,2, Mariam Z Quraishi1,2
1Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Pediatric blood & cancer
|January 7, 2026
まとめ
鎌状赤血球症(SCD)は、家族歴を考慮しても、子供たちの喘鳴のリスクを著しく高めます。有病率の年齢増加に伴い、SCDを持つ子供たちの喘鳴の定期的なスクリーニングが不可欠です。
背景:
- 鎌状赤血球症(SCD)と喘鳴は症状が重複しており、SCDが喘鳴リスクを高めるかどうかを判断するのは困難である。
- SCDを持つ子供たちの喘鳴有病率は、一般集団と同程度かそれ以上と考えられている。
主な方法:
- 前向き症例対照兄弟姉妹比較研究。
- 対象はSCDを持つ子供248名と兄弟姉妹328名(年齢2〜18歳)。
- 喘鳴の診断は、小児科呼吸器専門医による臨床評価で確認された。
主要な成果:
- SCDを持つ子供の喘鳴有病率は、兄弟姉妹と比較して有意に高かった(28.6% vs 7.6%)。
- SCDの有無は、年齢と性別を調整した後、喘鳴のオッズ(OR: 7.57)を増加させる唯一の要因であった。
- SCD群では、年齢、男性、喘鳴の家族歴、ヒドロキシウレアの使用がリスク因子として挙げられた。
結論:
- 鎌状赤血球症は、家族的および環境的影響に関係なく、喘鳴リスクを独立して増加させる。
- SCDを持つ子供たちの年齢とともに増加する喘鳴の有病率は、定期的なスクリーニングの必要性を強調している。
関連する概念動画
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Multiple Allele Traits
37.9K
The Concept of Multiple Allelism
37.9K


